Literature DB >> 15122669

Human imaging of phosphorus in cortical and trabecular bone in vivo.

Matthew D Robson1, Peter D Gatehouse, Graeme M Bydder, Stefan Neubauer.   

Abstract

Phosphorus was imaged in vivo in human cortical and trabecular bone and the T(1) and T(2) (*) were measured. An ultrashort TE (UTE) pulse sequence (TE = 70 microm) was used with half pulse excitation and radial mapping of k-space from the center out. T(2) (*) was measured using multiple echo times and T(1) was measured both by saturation recovery and by a method using different RF pulse amplitudes. Seven normal subjects (32-85 years) were examined. Phosphorus was imaged, with a true in-plane resolution of 2.9 x 2.9 mm and a signal-to-noise ratio (SNR) of 19:1, in both cortical and trabecular bone. The mean T(2) (*) value was 207 +/- 12 micros, and the mean T(1) value was 8.6 +/- 3.0 sec. Images and measurements were obtained in realistic times on a clinical MR system. This may provide a new approach to characterizing disease of bone. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122669     DOI: 10.1002/mrm.20055

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  24 in total

1.  Designing long-T2 suppression pulses for ultrashort echo time imaging.

Authors:  Peder E Z Larson; Paul T Gurney; Krishna Nayak; Garry E Gold; John M Pauly; Dwight G Nishimura
Journal:  Magn Reson Med       Date:  2006-07       Impact factor: 4.668

2.  Using adiabatic inversion pulses for long-T2 suppression in ultrashort echo time (UTE) imaging.

Authors:  Peder E Z Larson; Steven M Conolly; John M Pauly; Dwight G Nishimura
Journal:  Magn Reson Med       Date:  2007-11       Impact factor: 4.668

Review 3.  Magnetic Resonance Imaging of Hard Tissues and Hard Tissue Engineered Bio-substitutes.

Authors:  Simone Mastrogiacomo; Weiqiang Dou; John A Jansen; X Frank Walboomers
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

4.  Bone mineral (31)P and matrix-bound water densities measured by solid-state (31)P and (1)H MRI.

Authors:  Alan C Seifert; Cheng Li; Chamith S Rajapakse; Mahdieh Bashoor-Zadeh; Yusuf A Bhagat; Alexander C Wright; Babette S Zemel; Antonios Zavaliangos; Felix W Wehrli
Journal:  NMR Biomed       Date:  2014-05-21       Impact factor: 4.044

5.  Phosphorus-31 MRI of hard and soft solids using quadratic echo line-narrowing.

Authors:  Merideth A Frey; Michael Michaud; Joshua N VanHouten; Karl L Insogna; Joseph A Madri; Sean E Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

6.  Bone matrix imaged in vivo by water- and fat-suppressed proton projection MRI (WASPI) of animal and human subjects.

Authors:  Yaotang Wu; Mirko I Hrovat; Jerome L Ackerman; Timothy G Reese; Haihui Cao; Kirsten Ecklund; Melvin J Glimcher
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

7.  Quantitative (31)P NMR spectroscopy and (1)H MRI measurements of bone mineral and matrix density differentiate metabolic bone diseases in rat models.

Authors:  Haihui Cao; Ara Nazarian; Jerome L Ackerman; Brian D Snyder; Andrew E Rosenberg; Rosalynn M Nazarian; Mirko I Hrovat; Guangping Dai; Dionyssios Mintzopoulos; Yaotang Wu
Journal:  Bone       Date:  2010-02-24       Impact factor: 4.398

8.  Bone quality assessment techniques: geometric, compositional, and mechanical characterization from macroscale to nanoscale.

Authors:  Heather B Hunt; Eve Donnelly
Journal:  Clin Rev Bone Miner Metab       Date:  2016-08-22

9.  Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment.

Authors:  S Anumula; S L Wehrli; J Magland; A C Wright; F W Wehrli
Journal:  Bone       Date:  2010-01-21       Impact factor: 4.398

Review 10.  Evaluating bone quality in patients with chronic kidney disease.

Authors:  Hartmut H Malluche; Daniel S Porter; David Pienkowski
Journal:  Nat Rev Nephrol       Date:  2013-10-08       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.